Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-24 Parker Braden C. Chief Commercial Officer Shares withheld for taxes −29,323 $5.07 $149K 75,677
2026-07-15 Lutz Robert Matthew Chief Fin. & Operating Officer Grant or award +35,000 328,977
2026-07-15 Lutz Robert Matthew Chief Fin. & Operating Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion +75,000 $1.59 $119K 611,032
2026-06-22 Lowrance David L Chief Financial Officer Shares withheld for taxes −21,682 $5.50 $119K 589,350
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion +129,350 $1.23 $159K 718,700
2026-06-22 Lowrance David L Chief Financial Officer Shares withheld for taxes −28,928 $5.50 $159K 689,772
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion +56,937 $1.11 $63K 746,709
2026-06-22 Lowrance David L Chief Financial Officer Shares withheld for taxes −11,491 $5.50 $63K 735,218
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion +218,750 $1.51 $330K 953,968
2026-06-22 Lowrance David L Chief Financial Officer Shares withheld for taxes −60,057 $5.50 $330K 893,911
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion +12,500 $4.45 $56K 906,411
2026-06-22 Lowrance David L Chief Financial Officer Shares withheld for taxes −10,114 $5.50 $56K 896,297
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion +87,650 $3.35 $294K 983,947
2026-06-22 Lowrance David L Chief Financial Officer Shares withheld for taxes −53,387 $5.50 $294K 930,560
2026-06-22 Lowrance David L Chief Financial Officer Sale −394,528 $5.68 $2.2M 536,032
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −75,000 0
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −129,350 0
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −56,937 0
2026-06-22 Lowrance David L Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −218,750 31,250

Page 1 of 20 · 390 trades